The first real-world analysis of tinnitus patients treated with Lenire in the United States has been submitted to a journal for peer-review and is now available on an online pre-print server for health services, medRxiv.
Real-world results are consistent with Lenire’s large-scale clinical trial results.
91.5% of patients experienced clinically meaningful reduction in tinnitus after 12-weeks of treatment with Lenire.
89.2% of patients indicated they benefited from treatment with Lenire.
220 patient treatment results were analyzed for the review making the paper one of the largest real-world analyses of tinnitus patients ever conducted.
